Gossamer Bio Investors Face June Deadline in Securities Lawsuit Over Hidden Study Data
Rosen Law Firm urges Gossamer Bio investors to meet June 1 securities lawsuit deadline, alleging concealed Phase 3 trial design flaws while making positive statements.
GOSSsecurities class actionlead plaintiff deadline